Stock Events

Stock Events

Halozyme Therapeutics (RV7.STU) Q1 2026 Earnings

17FebConfirmed

Q1 2026

-0.2

0.48

1.17

1.85

Details

Expected EPS

1.85427676

Actual EPS

-0.2024688

Surprise EPS

-2.06

Surprise Percent

+110.92%

Description

Halozyme Therapeutics (RV7.STU) has reported earnings of -0.2024688 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.